Mr Roberto Casula

Mr Roberto Casula, Consultant in Cardiothoracic Surgery, was appointed Head of the Cardiothoracic department at Imperial College London NHS Trust in 2020.  He is highly experienced in performing traditional and key-hole heart procedures and led successfully the Robotic Cardiac Surgical program at St Mary's Hospital in Paddington in 2003-2009 then he has led the Minimal access valves and revascularisation program at The Hammersmith Hospital from 2010 to date at Imperial College, London. He was the first surgeon to perform robotic totally endoscopic minimally invasive heart procedures in the UK in 2003. Mr Casula began his medical education in Italy graduating from Padova University Medical School in 1989. He then went on to train in the UK in cardiac, thoracic surgery and thoracic organs transplantation.  He is currently registered with the General Medical Council and is a fellow for the Royal College of Surgeons in England. He has consistently offered his patients access to minimally invasive procedures like coronary revascularisation, mitral, tricuspid valve repair and replacements, minimal access aortic valve replacements and minimal access surgical or hybrid atrial fibrillation ablation. His expertise extends beyond the UK, with him being invited as a visiting surgeon to many prestigious institutions in Milan, Bologna, Bari, Florence, Pisa, Udine, Athens, the Middle East and the West Indies. He has performed over 7000 major cardiac surgeries. He has a keen academic interest, being published by the Society for Cardiothoracic Surgery regularly. His main research interests centre around new surgical technology and innovation, robotics and assessments of elderly frailty. He has published over 100 peer-reviewed articles and a textbook on minimally invasive thoracic and cardiac surgery.

He has consistently offered his patients access to minimally invasive procedures like coronary revascularisation, mitral, tricuspid valve repair and replacements, minimal access aortic valve replacements and minimal access surgical or hybrid atrial fibrillation ablation.